- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06313931
Effects of Cognitive-motor Training on Cognition, Depression and Daily Functioning in Patients With Mild Cognitive Impairment (MCI)
Effects of Cognitive-motor Training on Cognition, Depression and Daily Functioning in Patients With Mild Cognitive Impairment (MCI): A Randomized Controlled Trial
Study Overview
Status
Conditions
Detailed Description
Background:
The increase in cases of MCI underlines the urgency of finding effective methods to slow its progression. Given the limited effectiveness of current pharmacological options to prevent or treat the early stages of this deterioration, non-pharmacological alternatives are especially relevant.
Aim: The study aimed to evaluate the effectiveness of an immersive virtual reality (IVR) application, focused on an activity of daily living (ADL), to train cognitive functions and its impact on depression and the ability to perform ADL in patients with MCI. IVR is presented as an innovative tool with the potential to offer a promising non-pharmacological approach.
Methods:The researchers implemented a 40-minute-long intervention, twice a week for six weeks (totaling 12 sessions), using the cupboard task (based on IVR). The study included the participation of individuals with MCI, randomly distributed into control (n=12) and experimental (n=14) groups. The majority in the control group were women (75%), with a mean age of 77.67 years, and in the experimental group, women represented 57.14%, with a mean age of 74.86 years. Cognitive functions, depression, and the ability to perform ADLs were assessed. The scales used were: the Spanish version of the Montreal Cognitive Assessment (MoCA-S), the Short Geriatric Depression Scale (SGDS-S) and the Instrumental Activities of Daily Living Scale. (IADL-S), respectively.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Teruel, Spain, 44003
- University of Zaragoza
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 65 or older
- Community-dwelling, not in nursing homes
- Physically functional
- Understanding and voluntary consent
- Mild Cognitive Impairment (MCI)
- MoCA score of 19-25
Exclusion Criteria:
- Clinical dementia diagnosis
- MoCA ≤ 18 indicating probable dementia
- Neurological disorders including stroke or TBI in the last year
- History of mental/psychiatric disorders
- Substance abuse
- Difficulty using VR headset and controllers
- Medical conditions affecting trial participation
- Visual/hearing impairments
- Communication difficulties
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control group
|
motor stimulation for 12 sessions (20 minutes per session)
20 minutes per session, twice a week for six weeks (totaling 12 sessions), using cards.
|
Experimental: Experimental group
|
20 minutes per session, twice a week for six weeks (totaling 12 sessions), using the cupboard task application.
motor stimulation for 12 sessions (20 minutes per session)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Spanish version of the Montreal Cognitive Assessment (MoCA-S)
Time Frame: 6 weeks
|
Scores in the MoCA-S scale.
Higher scores mean a better outcome.
|
6 weeks
|
Short Geriatric Depression Scale (SGDS-S)
Time Frame: 6 weeks
|
Scores in the SGDS scale.
Higher scores mean a worse outcome.
|
6 weeks
|
Instrumental Activities of Daily Living Scale (IADL-S)
Time Frame: 6 weeks
|
Scores in the IADL scale.
Higher scores mean a better outcome.
|
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Guillermo Palacios, PhD, Universidad de Zaragoza
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UTI-IIDI-074-2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.RecruitingMild Cognitive Impairment (MCI)Taiwan
-
Thomas Jefferson UniversityJohns Hopkins University; University of Pennsylvania; National Institute on Aging... and other collaboratorsCompletedMild Cognitive Impairment (MCI)United States
-
Palo Alto Veterans Institute for ResearchU.S. Army Medical Research and Development CommandCompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Assaf-Harofeh Medical CenterNeurim Pharmaceuticals Ltd.UnknownMild Cognitive Impairment (MCI)Israel
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaboratorsRecruitingAmnestic Mild Cognitive ImpairmentChina
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
Jennifer BramenNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Meir Medical CenterTerminatedMild Cognitive Impairment (MCI)Israel
Clinical Trials on cognitive training via immersive virtual reality
-
St. Jude Children's Research HospitalRecruitingBrain TumorUnited States
-
I.R.C.C.S. Fondazione Santa LuciaRecruitingStroke | Neglect, HemispatialItaly
-
Acibadem UniversityKartal Dr. Lütfi Kirdar City HospitalCompletedRheumatoid Arthritis | Chronic Pain | Virtual RealityTurkey
-
Kessler FoundationCompletedTraumatic Brain InjuryUnited States
-
Tufts UniversityTufts Clinical and Translational Science InstituteCompleted
-
Copenhagen Academy for Medical Education and SimulationCompleted
-
Groupe Hospitalier Paris Saint JosephActive, not recruitingChronic Low-back PainFrance
-
Sheffield Hallam UniversityMedical Research CouncilCompletedUpper Extremity Fracture | Burn; Arm | Exostosis of Elbow | Burn ScaldUnited Kingdom
-
Mindmaze SAUniversity of Lausanne HospitalsRecruitingStroke | Attention DisorderSwitzerland